TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA. VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - El-Serag, H. B. PY - 2012 DA - 2012// TI - Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma JO - Gastroenterology VL - 142 UR - https://doi.org/10.1053/j.gastro.2011.12.061 DO - 10.1053/j.gastro.2011.12.061 ID - El-Serag2012 ER - TY - JOUR AU - Belghiti, J. AU - Fuks, D. PY - 2012 DA - 2012// TI - Liver Resection and Transplantation in Hepatocellular Carcinoma JO - Liver Cancer VL - 1 UR - https://doi.org/10.1159/000342403 DO - 10.1159/000342403 ID - Belghiti2012 ER - TY - JOUR AU - Llovet, J. M. AU - Ricci, S. AU - Mazzaferro, V. AU - Hilgard, P. AU - Gane, E. AU - Blanc, J. -. F. PY - 2008 DA - 2008// TI - Sorafenib in advanced hepatocellular carcinoma JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708857 DO - 10.1056/NEJMoa0708857 ID - Llovet2008 ER - TY - JOUR AU - Cheng, A. -. L. AU - Kang, Y. -. K. AU - Chen, Z. AU - Tsao, C. -. J. AU - Qin, S. AU - Kim, J. S. PY - 2009 DA - 2009// TI - Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(08)70285-7 DO - 10.1016/S1470-2045(08)70285-7 ID - Cheng2009 ER - TY - JOUR AU - Kudo, M. AU - Finn, R. S. AU - Qin, S. AU - Han, K. -. H. AU - Ikeda, K. AU - Piscaglia, F. PY - 2018 DA - 2018// TI - Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial JO - The Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30207-1 DO - 10.1016/S0140-6736(18)30207-1 ID - Kudo2018 ER - TY - JOUR AU - Bruix, J. AU - Qin, S. AU - Merle, P. AU - Granito, A. AU - Huang, Y. -. H. AU - Bodoky, G. PY - 2017 DA - 2017// TI - Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)32453-9 DO - 10.1016/S0140-6736(16)32453-9 ID - Bruix2017 ER - TY - JOUR AU - Abou-Alfa, G. K. AU - Meyer, T. AU - Cheng, A. -. L. AU - El-Khoueiry, A. B. AU - Rimassa, L. AU - Ryoo, B. -. Y. PY - 2018 DA - 2018// TI - Cabozantinib in patients with advanced and progressing hepatocellular carcinoma JO - N Engl J Med VL - 379 UR - https://doi.org/10.1056/NEJMoa1717002 DO - 10.1056/NEJMoa1717002 ID - Abou-Alfa2018 ER - TY - JOUR AU - Lemmon, M. A. AU - Schlessinger, J. PY - 2010 DA - 2010// TI - Cell signaling by receptor tyrosine kinases JO - Cell VL - 141 UR - https://doi.org/10.1016/j.cell.2010.06.011 DO - 10.1016/j.cell.2010.06.011 ID - Lemmon2010 ER - TY - JOUR AU - Jura, N. AU - Zhang, X. AU - Endres Nicholas, F. AU - Seeliger Markus, A. AU - Schindler, T. AU - Kuriyan, J. PY - 2011 DA - 2011// TI - Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms JO - Mol Cell VL - 42 UR - https://doi.org/10.1016/j.molcel.2011.03.004 DO - 10.1016/j.molcel.2011.03.004 ID - Jura2011 ER - TY - JOUR AU - Ooi, A. AU - Takehana, T. AU - Li, X. AU - Suzuki, S. AU - Kunitomo, K. AU - Iino, H. PY - 2004 DA - 2004// TI - Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study JO - Mod Pathol VL - 17 UR - https://doi.org/10.1038/modpathol.3800137 DO - 10.1038/modpathol.3800137 ID - Ooi2004 ER - TY - JOUR AU - Selvaggi, G. AU - Novello, S. AU - Torri, V. AU - Leonardo, E. AU - Giuli, P. AU - Borasio, P. PY - 2004 DA - 2004// TI - Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh011 DO - 10.1093/annonc/mdh011 ID - Selvaggi2004 ER - TY - JOUR AU - Lynch, T. J. AU - Bell, D. W. AU - Sordella, R. AU - Gurubhagavatula, S. AU - Okimoto, R. A. AU - Brannigan, B. W. PY - 2004 DA - 2004// TI - Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa040938 DO - 10.1056/NEJMoa040938 ID - Lynch2004 ER - TY - JOUR AU - Paez, J. G. AU - Jänne, P. A. AU - Lee, J. C. AU - Tracy, S. AU - Greulich, H. AU - Gabriel, S. PY - 2004 DA - 2004// TI - EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy JO - Science VL - 304 UR - https://doi.org/10.1126/science.1099314 DO - 10.1126/science.1099314 ID - Paez2004 ER - TY - JOUR AU - Tsao, M. -. S. AU - Sakurada, A. AU - Cutz, J. -. C. AU - Zhu, C. -. Q. AU - Kamel-Reid, S. AU - Squire, J. PY - 2005 DA - 2005// TI - Erlotinib in lung cancer—molecular and clinical predictors of outcome JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050736 DO - 10.1056/NEJMoa050736 ID - Tsao2005 ER - TY - JOUR AU - Riely, G. J. AU - Pao, W. AU - Pham, D. AU - Li, A. R. AU - Rizvi, N. AU - Venkatraman, E. S. PY - 2006 DA - 2006// TI - Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1846 DO - 10.1158/1078-0432.CCR-05-1846 ID - Riely2006 ER - TY - JOUR AU - Sharma, S. V. AU - Bell, D. W. AU - Settleman, J. AU - Haber, D. A. PY - 2007 DA - 2007// TI - Epidermal growth factor receptor mutations in lung cancer JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2088 DO - 10.1038/nrc2088 ID - Sharma2007 ER - TY - JOUR AU - Ito, Y. AU - Takeda, T. AU - Sakon, M. AU - Tsujimoto, M. AU - Higashiyama, S. AU - Noda, K. PY - 2001 DA - 2001// TI - Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma JO - Br J Cancer VL - 84 UR - https://doi.org/10.1054/bjoc.2000.1580 DO - 10.1054/bjoc.2000.1580 ID - Ito2001 ER - TY - JOUR AU - Ezzoukhry, Z. AU - Louandre, C. AU - Trécherel, E. AU - Godin, C. AU - Chauffert, B. AU - Dupont, S. PY - 2012 DA - 2012// TI - EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.27604 DO - 10.1002/ijc.27604 ID - Ezzoukhry2012 ER - TY - JOUR AU - Blivet-Van Eggelpoël, M. -. J. AU - Chettouh, H. AU - Fartoux, L. AU - Aoudjehane, L. AU - Barbu, V. AU - Rey, C. PY - 2012 DA - 2012// TI - Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells JO - J Hepatol VL - 57 UR - https://doi.org/10.1016/j.jhep.2012.02.019 DO - 10.1016/j.jhep.2012.02.019 ID - Blivet-Van Eggelpoël2012 ER - TY - JOUR AU - Buckley, A. F. AU - Burgart, L. J. AU - Sahai, V. AU - Kakar, S. PY - 2008 DA - 2008// TI - Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma JO - Am J Clin Pathol VL - 129 UR - https://doi.org/10.1309/WF10QAAED3PP93BH DO - 10.1309/WF10QAAED3PP93BH ID - Buckley2008 ER - TY - JOUR AU - Su, M. -. C. AU - Lien, H. -. C. AU - Jeng, Y. -. M. PY - 2005 DA - 2005// TI - Absence of epidermal growth factor receptor exon 18–21 mutation in hepatocellular carcinoma JO - Cancer Lett VL - 224 UR - https://doi.org/10.1016/j.canlet.2004.10.010 DO - 10.1016/j.canlet.2004.10.010 ID - Su2005 ER - TY - JOUR AU - Lee, S. -. C. AU - Lim, S. -. G. AU - Soo, R. AU - Hsieh, W. -. S. AU - Guo, J. -. Y. AU - Putti, T. PY - 2006 DA - 2006// TI - Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma JO - Pharmacogenet Genomics VL - 16 UR - https://doi.org/10.1097/01.fpc.0000184959.82903.02 DO - 10.1097/01.fpc.0000184959.82903.02 ID - Lee2006 ER - TY - JOUR AU - Panvichian, R. AU - Tantiwetrueangdet, A. AU - Sornmayura, P. AU - Leelaudomlipi, S. PY - 2015 DA - 2015// TI - Missense mutations in exons 18–24 of EGFR in hepatocellular carcinoma tissues JO - Biomed Res Int VL - 2015 UR - https://doi.org/10.1155/2015/171845 DO - 10.1155/2015/171845 ID - Panvichian2015 ER - TY - JOUR AU - Zhang, X. AU - Gureasko, J. AU - Shen, K. AU - Cole, P. A. AU - Kuriyan, J. PY - 2006 DA - 2006// TI - An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor JO - Cell VL - 125 UR - https://doi.org/10.1016/j.cell.2006.05.013 DO - 10.1016/j.cell.2006.05.013 ID - Zhang2006 ER - TY - JOUR AU - Stamos, J. AU - Sliwkowski, M. X. AU - Eigenbrot, C. PY - 2002 DA - 2002// TI - Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M207135200 DO - 10.1074/jbc.M207135200 ID - Stamos2002 ER - TY - JOUR AU - Eierhoff, T. AU - Hrincius, E. R. AU - Rescher, U. AU - Ludwig, S. AU - Ehrhardt, C. PY - 2010 DA - 2010// TI - The Epidermal growth factor receptor (EGFR) promotes uptake of influenza a viruses (IAV) into host cells JO - PLoS Pathog VL - 6 UR - https://doi.org/10.1371/journal.ppat.1001099 DO - 10.1371/journal.ppat.1001099 ID - Eierhoff2010 ER - TY - JOUR AU - Yu, S. AU - Zhang, Y. AU - Pan, Y. AU - Cheng, C. AU - Sun, Y. AU - Chen, H. PY - 2017 DA - 2017// TI - The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive JO - Onco Targets Ther VL - 10 UR - https://doi.org/10.2147/OTT.S131999 DO - 10.2147/OTT.S131999 ID - Yu2017 ER - TY - JOUR AU - Ullrich, A. AU - Coussens, L. AU - Hayflick, J. S. AU - Dull, T. J. AU - Gray, A. AU - Tam, A. W. PY - 1984 DA - 1984// TI - Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells JO - Nature VL - 309 UR - https://doi.org/10.1038/309418a0 DO - 10.1038/309418a0 ID - Ullrich1984 ER - TY - JOUR AU - Roskoski, R. PY - 2019 DA - 2019// TI - Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers JO - Pharmacol Res VL - 139 UR - https://doi.org/10.1016/j.phrs.2018.11.014 DO - 10.1016/j.phrs.2018.11.014 ID - Roskoski2019 ER - TY - JOUR AU - Kaufmann, S. H. AU - Desnoyers, S. AU - Ottaviano, Y. AU - Davidson, N. E. AU - Poirier, G. G. PY - 1993 DA - 1993// TI - Specific proteolytic cleavage of Poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis JO - Can Res VL - 53 ID - Kaufmann1993 ER - TY - JOUR AU - Mizushima, N. AU - Yoshimori, T. PY - 2007 DA - 2007// TI - How to Interpret LC3 Immunoblotting JO - Autophagy VL - 3 UR - https://doi.org/10.4161/auto.4600 DO - 10.4161/auto.4600 ID - Mizushima2007 ER - TY - JOUR AU - Shan, Y. AU - Eastwood Michael, P. AU - Zhang, X. AU - Kim Eric, T. AU - Arkhipov, A. AU - Dror Ron, O. PY - 2012 DA - 2012// TI - Oncogenic mutations counteract intrinsic disorder in the egfr kinase and promote receptor dimerization JO - Cell VL - 149 UR - https://doi.org/10.1016/j.cell.2012.02.063 DO - 10.1016/j.cell.2012.02.063 ID - Shan2012 ER - TY - JOUR AU - Sutto, L. AU - Gervasio, F. L. PY - 2013 DA - 2013// TI - Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase JO - Proc Natl Acad Sci VL - 110 UR - https://doi.org/10.1073/pnas.1221953110 DO - 10.1073/pnas.1221953110 ID - Sutto2013 ER - TY - JOUR AU - Kancha, R. K. AU - Peschel, C. AU - Duyster, J. PY - 2011 DA - 2011// TI - The epidermal growth factor receptor-l861q mutation increases kinase activity without leading to enhanced sensitivity toward epidermal growth factor receptor kinase inhibitors JO - J Thorac Oncol VL - 6 UR - https://doi.org/10.1097/JTO.0b013e3182021f3e DO - 10.1097/JTO.0b013e3182021f3e ID - Kancha2011 ER - TY - JOUR AU - Gong, Y. AU - Somwar, R. AU - Politi, K. AU - Balak, M. AU - Chmielecki, J. AU - Jiang, X. PY - 2007 DA - 2007// TI - Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas JO - PLOS Med VL - 4 UR - https://doi.org/10.1371/journal.pmed.0040294 DO - 10.1371/journal.pmed.0040294 ID - Gong2007 ER - TY - JOUR AU - Costa, D. B. AU - Halmos, B. AU - Kumar, A. AU - Schumer, S. T. AU - Huberman, M. S. AU - Boggon, T. J. PY - 2007 DA - 2007// TI - BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations JO - PLOS Med VL - 4 UR - https://doi.org/10.1371/journal.pmed.0040315 DO - 10.1371/journal.pmed.0040315 ID - Costa2007 ER - TY - JOUR AU - Cragg, M. S. AU - Kuroda, J. AU - Puthalakath, H. AU - Huang, D. C. S. AU - Strasser, A. PY - 2007 DA - 2007// TI - Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 Mimetics JO - PLOS Med VL - 4 UR - https://doi.org/10.1371/journal.pmed.0040316 DO - 10.1371/journal.pmed.0040316 ID - Cragg2007 ER - TY - JOUR AU - Wei, Y. AU - Zou, Z. AU - Becker, N. AU - Anderson, M. AU - Sumpter, R. AU - Xiao, G. PY - 2013 DA - 2013// TI - EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance JO - Cell VL - 154 UR - https://doi.org/10.1016/j.cell.2013.08.015 DO - 10.1016/j.cell.2013.08.015 ID - Wei2013 ER - TY - JOUR AU - Zhao, Z. -. Q. AU - Yu, Z. -. Y. AU - Li, J. AU - Ouyang, X. -. N. PY - 2016 DA - 2016// TI - Gefitinib induces lung cancer cell autophagy and apoptosis via blockade of the PI3K/AKT/mTOR pathway JO - Oncol Lett VL - 12 UR - https://doi.org/10.3892/ol.2016.4606 DO - 10.3892/ol.2016.4606 ID - Zhao2016 ER - TY - JOUR AU - Cicchini, M. AU - Karantza, V. AU - Xia, B. PY - 2015 DA - 2015// TI - Molecular pathways: autophagy in cancer–a matter of timing and context JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-13-2438 DO - 10.1158/1078-0432.CCR-13-2438 ID - Cicchini2015 ER - TY - JOUR AU - Russell, R. C. AU - Tian, Y. AU - Yuan, H. AU - Park, H. W. AU - Chang, Y. Y. AU - Kim, J. PY - 2013 DA - 2013// TI - ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase JO - Nat Cell Biol VL - 15 UR - https://doi.org/10.1038/ncb2757 DO - 10.1038/ncb2757 ID - Russell2013 ER - TY - JOUR AU - Klionsky, D. J. AU - Schulman, B. A. PY - 2014 DA - 2014// TI - Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins JO - Nat Struct Mol Biol VL - 21 UR - https://doi.org/10.1038/nsmb.2787 DO - 10.1038/nsmb.2787 ID - Klionsky2014 ER - TY - JOUR AU - Yu, X. AU - Long, Y. C. AU - Shen, H. -. M. PY - 2015 DA - 2015// TI - Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy JO - Autophagy VL - 11 UR - https://doi.org/10.1080/15548627.2015.1043076 DO - 10.1080/15548627.2015.1043076 ID - Yu2015 ER -